TKNO

TKNO

USD

Alpha Teknova Inc. Common Stock

$6.520-0.240 (-3.550%)

リアルタイム価格

Healthcare
Drug Manufacturers - Specialty & Generic
米国

価格チャート

Loading Chart...

主要指標

市場指標
企業ファンダメンタルズ
取引統計

市場指標

始値

$6.760

高値

$6.850

安値

$6.500

出来高

0.03M

企業ファンダメンタルズ

時価総額

348.4M

業種

Drug Manufacturers - Specialty & Generic

United States

取引統計

平均出来高

0.45M

取引所

NGM

通貨

USD

52週レンジ

安値 $1.155現在値 $6.520高値 $10.37

AI分析レポート

最終更新: 2025年5月2日
AIによる生成データソース: Yahoo Finance, Bloomberg, SEC

TKNO (Alpha Teknova Inc. Common Stock): Analyzing Recent Moves & What Might Come Next

Stock Symbol: TKNO Generate Date: 2025-05-02 17:05:32

Alright, let's break down what's happening with Alpha Teknova, ticker symbol TKNO. Think of this as looking under the hood to see what the recent news, price action, and some AI predictions might suggest.

The Latest Buzz: Earnings on the Horizon

The main piece of news we've got is pretty straightforward: Teknova plans to announce their first-quarter financial results on May 8th. This isn't news about a big new product or a problem, just a date for sharing their report card.

Why does this matter? Well, earnings reports are a big deal for any stock. They give investors a look at how the company is actually doing – are they making more money? Less? Are their costs under control? The numbers they report, and what the company says about the future, can really move the stock price, sometimes quite a bit. So, that May 8th date is definitely one to circle if you're watching TKNO.

Interestingly, some AI analysis points to recent news sentiment being quite positive overall, even with this specific announcement being neutral on its face. This could mean there's been other positive chatter or anticipation building around these upcoming results.

Checking the Price Tag: What the Chart Shows

Looking back over the last few months, TKNO's stock price has been on a bit of a rollercoaster. It started off around the $8-$9 mark back in February, but then saw a pretty significant slide, dipping down into the $5-$6 range by early March.

Since hitting those lows, the price has shown signs of life. It's been gradually climbing back up, though with some ups and downs along the way. Lately, it's been trading in the mid-$6 range, recovering some ground from those earlier dips. The current price is sitting right around $6.68.

Now, what about the very near future? An AI model is predicting a slight upward nudge for the stock over the next couple of days, suggesting potential gains of around 3% or so. This aligns with the recent trend of recovery we've seen.

Putting It Together: What Does This All Suggest?

Based on the information at hand – the upcoming earnings report acting as a potential catalyst, the stock's recent bounce back from lower levels, and the AI's short-term positive forecast – the near-term picture seems to lean cautiously positive.

Here's the thinking: The stock has already taken a hit and is now showing some upward momentum. The earnings report is the next big event, and if the numbers are good or the outlook is promising, that could fuel further gains. The AI prediction supports the idea of some upward movement happening soon.

Potential Strategy Ideas (Just things to think about, not advice!):

  • If you're considering getting in: The current price area, around $6.70, looks like a potential spot that some analysis points to. You might consider if this level makes sense for you, perhaps keeping the upcoming earnings date in mind – sometimes waiting until after the report gives more clarity, though you risk missing a move if the news is good.
  • Managing Risk: If you do decide to jump in, having a plan for when to get out is smart. A potential stop-loss level to consider, based on some analysis, might be around $5.96. This is below some recent trading lows and could help limit potential losses if the stock turns south unexpectedly.
  • Thinking About Taking Profits: If the stock does move up, a potential target level mentioned is around $7.12. This could be a point to consider selling some or all of your shares to lock in gains.

Remember, these are just potential levels based on the data provided; the market can do anything!

A Little About the Company

Alpha Teknova is in the healthcare sector, specifically making important stuff (reagents) that other companies use to discover and develop new medicines, vaccines, and diagnostic tests. They serve labs, pharma companies, and research institutions.

It's worth noting that TKNO is considered a smaller company (its market value is around $357 million) and its stock doesn't trade a massive amount of shares every day compared to bigger companies. This can sometimes mean bigger price swings on less news. Also, like many companies focused on growth in this sector, they aren't currently profitable, which is reflected in their negative P/E ratio – though the provided data suggests their P/E is better than the average for their specific industry group. They also carry a fair bit of debt relative to their size.

The upcoming earnings report will shed more light on their financial health and growth trajectory, which is key for a company like this.


Disclaimer: This analysis is based solely on the provided data and is for informational purposes only. It is not financial advice. Stock investing involves risk, and you could lose money. Always do your own thorough research and consider consulting with a qualified financial advisor before making any investment decisions.

関連ニュース

GlobeNewswire

Teknova to Report First Quarter 2025 Financial Results on May 8, 2025

HOLLISTER, Calif., April 24, 2025 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. ("Teknova") (NASDAQ:TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies,

もっと見る
Teknova to Report First Quarter 2025 Financial Results on May 8, 2025

AI予測Beta

AI推奨

強気

更新日時: 2025年5月4日 20:11

弱気中立強気

77.6% 信頼度

リスクと取引

リスクレベル3/5
中リスク
適しているのは
バリュー
取引ガイド

エントリーポイント

$6.62

利確

$7.06

損切り

$5.88

主要因子

RSIは24.4で、売られすぎ状態を示しており、潜在的な強力な反転を示唆しています
K値18.3はD値21.2を下回り20以下であり、売られすぎの状態を示唆しています
DMIは弱気トレンドを示しており (ADX:22.5、+DI:5.7、-DI:17.7)、注意が必要です
現在の価格はサポートレベル(6.59ドル)に非常に接近しており、強力な買い機会を示唆しています
出来高は平均(5,866)の3.4倍で、極めて強い買い圧力を示しています
MACD -0.0345はシグナルライン-0.0231の下にあり、弱気クロスオーバーを示しています

最新情報を入手

価格アラートを設定し、AI分析の更新とリアルタイム市場ニュースを受け取る。